These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8569029)

  • 21. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.
    Kario K; Matsuo T; Kobayashi H; Matsuo M; Sakata T; Miyata T
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1114-20. PubMed ID: 7627704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
    Sørensen BB; Rao LV
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of coagulation factor VII with the risk of myocardial infarction in the Chinese.
    Cai Q; Chen J; Ma H; Song J; Xu M
    Chin Med J (Engl); 2000 Dec; 113(12):1059-63. PubMed ID: 11776135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
    Moor E; Silveira A; van't Hooft F; Suontaka AM; Eriksson P; Blombäck M; Hamsten A
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):655-64. PubMed ID: 7749878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor VII hyperactivity in the elderly.
    Kario K; Matsuo T; Nakao K
    Thromb Haemost; 1991 Jan; 65(1):25-7. PubMed ID: 2024236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postprandial factor VII metabolism: the effect of the R353Q and 10 bp polymorphisms.
    Roche HM; Black IL; Noone E; Tully AM; Whitehead AS; Gibney MJ
    Br J Nutr; 2000 May; 83(5):467-72. PubMed ID: 10953670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low plasma concentrations of coagulation factors II, VII and XI indicate increased risk among elderly with symptoms of heart failure.
    Alehagen U; Dahlström U; Lindahl TL
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):62-9. PubMed ID: 20040856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coagulation factor VII--new physiopathological and therapeutic aspects].
    Helleberg C; Hippe E; Ingerslev J
    Ugeskr Laeger; 1994 Aug; 156(34):4805-10. PubMed ID: 7992413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coagulation factor VII levels in uremic patients and theirs influence factors].
    Fang J; Xia LH; Wei WN; Song SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):730-2. PubMed ID: 15631649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of lipid-lowering treatment on factor VII profile in hyperlipidemic patients.
    Porreca E; Di Febbo C; Amore C; Di Castelnuovo A; Baccante G; Donati MB; Cuccurullo F; Iacoviello L
    Thromb Haemost; 2000 Nov; 84(5):789-93. PubMed ID: 11127857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.
    Miller GJ; Bauer KA; Barzegar S; Cooper JA; Rosenberg RD
    Thromb Haemost; 1996 May; 75(5):767-71. PubMed ID: 8725721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Increased fibrinogen and factor VII activity levels in patients after myocardial infarction].
    Mamont B; Sawicka B
    Kardiol Pol; 1992 Nov; 37(11):283-6. PubMed ID: 1287288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of warfarin therapy on activated factor VII clotting activity.
    Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism.
    Okura Y; Hayashi K; Shingu T; Kuga Y; Nomura S; Kajiyama G; Nakashima Y; Saku K
    Coron Artery Dis; 2003 Jun; 14(4):285-91. PubMed ID: 12826927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations.
    Jensen JS
    Dan Med Bull; 2000 Apr; 47(2):63-78. PubMed ID: 10822799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms.
    Grimaudo S; Craxi A; Gentile S; Di Paolantonio T; Vaccaro A; Venezia G; Lo Coco L; Savella R; Usticano A; Capone F; Mariani G
    Dig Liver Dis; 2005 Jun; 37(6):446-50. PubMed ID: 15893284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
    Chu AJ; Wang ZG; Fox MJ
    Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
    Carvalho de Sousa J; Bruckert E; Soria C; Caen JP
    Nouv Rev Fr Hematol (1978); 1989; 31(1):13-5. PubMed ID: 2915918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Factor VII for a molecular marker in hypercoagulable state].
    Takamiya O; Okumura N
    Rinsho Byori; 1993 Jan; 41(1):83-7. PubMed ID: 8355413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
    Danielsen R; Onundarson PT; Thors H; Vidarsson B; Morrissey JH
    Scand Cardiovasc J; 1998; 32(2):87-95. PubMed ID: 9636964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.